BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 11602631)

  • 21. Interleukin-1beta induces glycosaminoglycan synthesis via the prostaglandin E2 pathway in cultured human cervical fibroblasts.
    Schmitz T; Leroy MJ; Dallot E; Breuiller-Fouche M; Ferre F; Cabrol D
    Mol Hum Reprod; 2003 Jan; 9(1):1-8. PubMed ID: 12529415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-prostanoid (EP)2/EP4 receptor-dependent maturation of human monocyte-derived dendritic cells and induction of helper T2 polarization.
    Kubo S; Takahashi HK; Takei M; Iwagaki H; Yoshino T; Tanaka N; Mori S; Nishibori M
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1213-20. PubMed ID: 14872092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression pattern of prostaglandin E synthase and EP receptor isoforms in normal mouse skin and preinvasive skin neoplasms.
    Neumann M; Dülsner E; Fürstenberger G; Müller-Decker K
    Exp Dermatol; 2007 May; 16(5):445-53. PubMed ID: 17437488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of prostaglandin E2-receptor EP2 and EP4 pathways induces growth inhibition in human gastric carcinoma cell lines.
    Okuyama T; Ishihara S; Sato H; Rumi MA; Kawashima K; Miyaoka Y; Suetsugu H; Kazumori H; Cava CF; Kadowaki Y; Fukuda R; Kinoshita Y
    J Lab Clin Med; 2002 Aug; 140(2):92-102. PubMed ID: 12228765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
    Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists.
    Shinomiya S; Naraba H; Ueno A; Utsunomiya I; Maruyama T; Ohuchida S; Ushikubi F; Yuki K; Narumiya S; Sugimoto Y; Ichikawa A; Oh-ishi S
    Biochem Pharmacol; 2001 May; 61(9):1153-60. PubMed ID: 11301049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis.
    Ma X; Kundu N; Rifat S; Walser T; Fulton AM
    Cancer Res; 2006 Mar; 66(6):2923-7. PubMed ID: 16540639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E2 augments IL-10 signaling and function.
    Cheon H; Rho YH; Choi SJ; Lee YH; Song GG; Sohn J; Won NH; Ji JD
    J Immunol; 2006 Jul; 177(2):1092-100. PubMed ID: 16818766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
    Chun KS; Akunda JK; Langenbach R
    Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E(2) inhibits IL-18-induced ICAM-1 and B7.2 expression through EP2/EP4 receptors in human peripheral blood mononuclear cells.
    Takahashi HK; Iwagaki H; Yoshino T; Mori S; Morichika T; Itoh H; Yokoyama M; Kubo S; Kondo E; Akagi T; Tanaka N; Nishibori M
    J Immunol; 2002 May; 168(9):4446-54. PubMed ID: 11970988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The expression of prostaglandin E receptors EP2 and EP4 and their different regulation by lipopolysaccharide in C3H/HeN peritoneal macrophages.
    Ikegami R; Sugimoto Y; Segi E; Katsuyama M; Karahashi H; Amano F; Maruyama T; Yamane H; Tsuchiya S; Ichikawa A
    J Immunol; 2001 Apr; 166(7):4689-96. PubMed ID: 11254729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice.
    Miyaura C; Inada M; Suzawa T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
    J Biol Chem; 2000 Jun; 275(26):19819-23. PubMed ID: 10749873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation.
    Miyamoto M; Ito H; Mukai S; Kobayashi T; Yamamoto H; Kobayashi M; Maruyama T; Akiyama H; Nakamura T
    Osteoarthritis Cartilage; 2003 Sep; 11(9):644-52. PubMed ID: 12954235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Four PGE2 EP receptors are up-regulated in injured nerve following partial sciatic nerve ligation.
    Ma W; Eisenach JC
    Exp Neurol; 2003 Oct; 183(2):581-92. PubMed ID: 14552899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4.
    Holt D; Ma X; Kundu N; Fulton A
    Cancer Immunol Immunother; 2011 Nov; 60(11):1577-86. PubMed ID: 21681369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of prostaglandin E(2) receptors and their role in 24,25-(OH)(2)D(3)-mediated effects on resting zone chondrocytes.
    Del Toro F; Sylvia VL; Schubkegel SR; Campos R; Dean DD; Boyan BD; Schwartz Z
    J Cell Physiol; 2000 Feb; 182(2):196-208. PubMed ID: 10623883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
    Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1.
    Katsuyama M; Ikegami R; Karahashi H; Amano F; Sugimoto Y; Ichikawa A
    Biochem Biophys Res Commun; 1998 Oct; 251(3):727-31. PubMed ID: 9790977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E prevents indomethacin-induced gastric and intestinal damage through different EP receptor subtypes.
    Kunikata T; Araki H; Takeeda M; Kato S; Takeuchi K
    J Physiol Paris; 2001; 95(1-6):157-63. PubMed ID: 11595431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired adrenocorticotropic hormone response to bacterial endotoxin in mice deficient in prostaglandin E receptor EP1 and EP3 subtypes.
    Matsuoka Y; Furuyashiki T; Bito H; Ushikubi F; Tanaka Y; Kobayashi T; Muro S; Satoh N; Kayahara T; Higashi M; Mizoguchi A; Shichi H; Fukuda Y; Nakao K; Narumiya S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4132-7. PubMed ID: 12642666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.